DR

Durgeswara Rao Katari

Active Director Director DIN 08686218
DIN 08686218 First appointment Jan 2020 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Durgeswara Rao Katari

Data last updated:

Durgeswara Rao Katari is a Director at Chemome Pharma Private Limited (since 2020). The company operates in Business Services.

DIN 08686218
Primary Designation Director
Industry Business Services
First Appointment 31 Jan 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chemome Pharma Private Limited U74999TG2020PTC138896
Director31 Jan 20202020Active

Board colleagues of Durgeswara Rao Katari

NameDINCompanyDesignation
Naga Ananta Lakshmi Mutyala08686219Chemome Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Chemome Pharma Private Limited
Premium access

Shareholding and investment profile for Durgeswara Rao Katari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Durgeswara Rao Katari

Durgeswara Rao Katari currently holds 1 directorship: Chemome Pharma Private Limited (Director, since 31 Jan 2020).

Durgeswara Rao Katari was first appointed on 31 Jan 2020 as Director at Chemome Pharma Private Limited.

The current boards of Durgeswara Rao Katari's companies include Naga Ananta Lakshmi Mutyala (Chemome Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available